Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 10,000 shares at $40.91 ($404K) on 2021-07-07, disclosed to the SEC on 2021-07-08.
Open-market sale of $404k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.16 | 3,505 | $141K | 34.9% |
| 2 | $40.16 | 3,505 | $141K | 34.9% |
| 3 | $40.91 | 1,495 | $61K | 15.1% |
| 4 | $40.91 | 1,495 | $61K | 15.1% |
| Total | $40.38 avg | 10,000 | $404K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |